Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Terminated

2(29%)

Phase Distribution

Ph not_applicable

14%

Ph early_phase_1

29%

Ph phase_1

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

2(40.0%)

Phase 1Safety & dosage

2(40.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(3)

Detailed Status

Completed4

Terminated2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 1

Trials by Phase

Early Phase 12 (40.0%)

Phase 12 (40.0%)

N/A1 (20.0%)

Trials by Status

completed457%

terminated229%

withdrawn114%

Recent Activity

0 active trials

Showing 5 of 7

completedearly_phase_1

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

NCT03578224

completedearly_phase_1

Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

NCT04185337

withdrawnphase_1

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

NCT05042934

terminatedphase_1

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

NCT00775268

terminated

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

NCT00813878

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03578224Early Phase 1

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Completed

NCT04185337Early Phase 1

Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

Completed

NCT05042934Phase 1

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Withdrawn

NCT00775268Phase 1

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

Terminated

NCT00813878

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Terminated

NCT01024582Not Applicable

Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer

Completed

NCT00952939

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Completed

All 7 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 7